CompletedNot Applicable

Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine

United States21 participantsStarted 2021-11-11

Plain-language summary

The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 to 65 years old with nausea associated migraines at least twice per month Exclusion Criteria: * Patients \<18 or \>65 years old * Patients without a diagnosis of acute migraine

What they're measuring

Change of Severity of Nausea on Nausea Scale

Timeframe: ½ hour or to the end of treatment

Trial details

NCT IDNCT05175521

SponsorHonorHealth Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Migraine trials